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Purpose. To describe the clinical characteristics, diagnosis, and treatment with intravitreal ampicillin sodium of a postoperative
endophthalmitis case due to Streptococcus uberis; an environmental pathogen commonly seen in mastitis cases of lactating cows.
Methods. Case Report. A 52-year-old, Hispanic diabetic patient who suddenly developed severe pain and severe loss of vision,
following vitrectomy. Results. The patient was diagnosed with postoperative endophthalmitis secondary to a highly resistant strain
of Streptococcus uberis that did not respond to intravitreal antibiotics. He was treated with an air-ﬂuid interchange, anterior
chamber washout, intravitreal ampicillin sodium (5mg/0.1mL), and silicon oil tamponade (5000ck). The eye was anatomically
stabilized, though there was no functional recovery. Conclusion. Streptococcus uberis is an uncommon pathogen to the human eye,
which has unique features that help the strain in developing resistance to antibiotics. While treatment with intravitreal ampicillin
is feasible, there are still concerns about its possible toxicity.
1.Introduction
Endophthalmitis is a rare postoperative complication which
ispotentiallydevastatingtovisualfunctionandthestructural
integrity of the eye [1]. In the postoperative setting, infection
generally occurs secondary to contamination with normal
periocular ﬂora. Occasionally, it develops from sources
which are diﬃcult to identify. Once detected postoperatively,
the condition is treated with intravitreal antibiotics and
vitrectomy and/or tap as per the recommendations of the
Endophthalmitis Vitrectomy Study (EVS) [2].
In recent years, there has been an increase of the number
of antibiotic-resistant bacterial strains and new strains which
are normally not part of the traditional etiological spectrum
of postoperative infection [3, 4]. The following case report
has the objective of describing the diagnosis, treatment,
and unfavorable evolution of one case of postoperative
endophthalmitis, secondary to Streptococcus uberis. This
environmental pathogen is commonly responsible for a high
proportion of cases of clinical (and subclinical) mastitis
in lactating cows [5]. The organism is highly resistant to
the majority of the latest generation antibiotics which are
commonly employed in the treatment of endophthalmitis.
Precisely how this patient became exposed to this pathogen
remains unclear.
2.CaseReport
A 52-year-old, Hispanic male presented to the retina depart-
ment of our hospital complaining of a three-month history
of progressive visual loss in his left eye. His past medical
history was remarkable for Diabetes Mellitus (18 years) with
poor metabolic control (last glucose level was 167mg/dL,
with a HbA1C of 14.7%), high blood pressure, chronic
renal failure (treated with peritoneal dialysis), and diabetic
ischemic foot problems (previous amputation of three toes).2 Journal of Ophthalmology
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Figure 1: (a): Patient’s B-mode ultrasonography, which shows areas of increased echogenicity in the vitreous cavity. (b) Vitreous cavity
sample gram stain that shows gran-positive cocci. ((c) and (d)) Antibiotic sensitivity tests. Blue arrow head: mild bacterial growth inhibition
secondary to moxiﬂoxacin disc. Yellow arrows: complete bacterial growth inhibition due to ampicillin sodium disc.
The patient also had history of previous abdominal surgeries
(23 years ago).
As for the ophthalmologic background, the patient had
a previous diagnosis of proliferative diabetic retinopathy,
which had been treated previously with bilateral panretinal
photocoagulation, and vitrectomy OD along with chronic
open angle glaucoma OU.
The best corrected visual acuity was 20/40 in OD
and counting ﬁngers at 30cm in OS, and the anterior
chamber examination was unremarkable. Ocular motility
and pupillary responses were normal. The lens in the
left eye was cataractous (C2N3P2, according to LOCS III
classiﬁcation), and intraocular pressure was 16mmHg OU.
Fundus examination revealed a dense vitreous hemorrhage
in the left eye. Ultrasound examination of the left eye
conﬁrmed the presence of low reﬂective mobile vitreous
opacities, consistent with vitreous hemorrhage, despite not
show, evidence of traction retinal detachment.
Based on the existing evidence, we decided to oﬀer
the patient phacoemulsiﬁcation surgery combined with a
23GA vitrectomy. The surgery was performed without
complications shortly after the initial examination, leaving
balanced saline solution in the vitreous cavity at the end
of the procedure. Although the vitrectomy ports were self-
sealing,wedecidedtoplaceasuture(8-0Vicryl,Ethicon,San
Angelo TX, USA) in all of them. We also placed a suture in
the phacoemulsiﬁcation incision (10-0 Nylon, Ethicon, San
Angelo TX, USA).
Twenty-four hours after surgery, the patient complained
of severe ocular pain, along with signiﬁcant reduction of
visual acuity (Hand Movements) and tearing. On ocu-
lar examination, we found severe conjunctival hyperemia,
ciliary injection, clear cornea, hypopyon in the anterior
chamber (1.2mm), and intraocular pressure of 30mmHg.
The posterior pole was not visible. The ultrasound exam-
ination revealed images of increased echogenicity which
correspond to cellularity in vitreous cavity, pseudomem-
branes formation, and choroidal thickening (Figure 1(a)).
The diagnosis of postoperative endophthalmitis was evident,
and we proceeded to immediately obtain aqueous and
vitreous cavity samples for staining, cultures, and sensitivity
tests.IntravitrealCeftazidime(2.25mg/0.1mL),Vancomycin
(1mg/0.1mL), and Dexamethasone (0.4mg/0.1mL) were
injected. The patient was admitted to the hospital, and
treatment was started with topical moxiﬂoxacin every hour
(Vigamox, Alcon Lab, Dallas Fort worth, TX) and oral
moxiﬂoxacin (400mg). The following day, the visual acuity
d e c r e a s e dt on ol i g h tp e r c e p t i o na n ds e v e r ep a i na n d
hypopyon continued. At the same day, the microbiology
department reported the presence of gram-positive cocciJournal of Ophthalmology 3
(a) (b)
(c) (d)
Figure 2: Patient’s clinical evolution: ((a) and (c)) previous air-ﬂuid interchange and intravitreal ampicillin sodium; the anterior segment
biomicroscopy showed severe conjunctival hyperemia, severe cellularity, and Hypopyon with a ﬁbrin clot on the surface of the intraocular
lens. The details of the retina cannot be observed due to signiﬁcant posterior opacities. However, the optic nerve seems to be extremely
pale with severe attenuation of the blood vessels. ((b) and (d)) Four weeks after second surgery; anterior segment biomicroscopy showed an
improvement in conjunctival hyperemia (mild), with disappearance of Hypopyon and ﬁbrin cloth, and the retina showed extensive areas of
photocoagulation (ﬁrst surgery), severe pallor of the optic nerve, bloodless vessels, and vitreous cavity ﬁlled with silicon oil.
in the vitreous cavity sample (which was classiﬁed as
Streptococcus uberis two days later (Figure 1(b)). The sen-
sitivity test documented resistance to cephalothin, cefo-
taxime, ceftazidime, cefuroxime, dicloxacillin, vancomycin,
azithromycin, clarithromycin, erythromycin, amikacin, gen-
tamicin, netilmicin, tobramycin, clindamycin polymyxin,
ciproﬂoxacin, gatiﬂoxacin, moxiﬂoxacin, oﬂoxacin, per-
ﬂoxacin, and tetracycline (Figures 1(c) and 1(d)). The only
known sensitivity was to ampicillin sodium.
Due to the lability of the patient and the possibility of
systemic dissemination of the bacteria, we oﬀered to the
patient an air-ﬂuid exchange, silicone oil as tamponade,
anterior chamber washout, and intraocular lens removal
after the failure of the ﬁrst intravitreal antibiotics. However,
the patient refused to sign the informed consent form
for the second surgery, delaying treatment for three days.
After knowing the speciﬁc sensitivity of the microorganism,
we added an intravitreal injection of ampicillin sodium
5mg/0.1mL to the original plan. Finally, after extensive and
exhaustive explanation, the patient agreed to the procedure.
The next day, the patient reported decreased pain, and
on examination the vision remained no light perception,
though there was no evidence of hypopyon and only mild
conjunctival hyperemia. The patient remained hospitalized
for the next three days, and during that time ampicillin
sodium was administered intravenously, at adjusted doses
of 1000mg bid according to creatinine clearance. After
discharge,thepatientcontinuedtreatmentwithmaintenance
dosesofintramuscularampicillinsodiumfortwoweeks.The
patient continued to improve. Four weeks later, the integrity
of the eye was preserved but the vision remained no light
perception (Figure 2).
3. Discussion
Despite the advances in surgical techniques and the tech-
nology available to perform ocular surgery, the incidence of
postoperative endophthalmitis in the last 10 years appears
to be increasing [6, 7]. What possibly play a role in this
development has been the indiscriminate and inappropriate
dosing of broad-spectrum antibiotics by doctors and the
inadequate compliance to full treatment duration by the
patients. This has led to the emergence of new resistant
strains to the latest generations of drugs [3, 4, 6]. Evidence
of this has been seen in the results published by the Ocular
Tracking Resistance in the U.S. Today (TRUST) program,
which reported an increase of 12.1% of methicillin-resistant4 Journal of Ophthalmology
Staphylococcus aureus (MRSA) strains, with more than 80%
of MRSA being resistant to ﬂuoroquinolones. However,
despite the considerable increase of this numbers, it is also
important to note that the study has the limitation that they
based the bacterial susceptibility to antibiotics on systemic
drug-exposure breakpoints and not in local concentration
(as in an intravitreal injection) [6].
Streptococcus uberis is an environmental pathogen which
is typically responsible for mastitis cases in lactating cows. It
is also the predominant organism isolated from mammary
glands during the nonlactating period in cows. Although
β-lactams are the treatment of choice, the bacteria possess
unique mechanism to generate resistance to antibiotics
like the mph(B) gene for resistance to macrolide and SOS
response-like DNA repair mechanism which may induce
SOS-driven adaptive mutations [5, 8]. The uncommon
strong resistance to antibiotics found in the strain cultured
from the patient’s vitreous samples could be the result of
all these conditions. The reason and circumstances by which
this microorganism was able to reach the eye remains hidden
to all of us.
Since there was no improvement clinically of our patient
after the ﬁrst intravitreal injection, and the isolated organism
was resistant to practically all the intravitreal antibiotics
that are commonly employed, we decided to use the only
antibiotic to which the organism appeared to be sensitive.
Our use of 5mg/0.1mL of intravitreal ampicillin sodium
was based on two previous reports in which the intravitreal
administration proved to be safe. Those reports were based
on unpublished data from G. A. Peyman in which he
established that the ampicillin sodium could be safely
administered intraocularly up to a dose of 10mg/0.1mL.
However, although the results were published in his book,
the original study was never published [9, 10].
The fact that almost all the traditional pathogens respon-
sible for endophthalmitis cases are beta-lactamase producing
strains limits the use of this antibiotic as part of the ﬁrst
choice drugs for the treatment of postoperative endoph-
thalmitis. The possibility of toxicity-induced damage due to
ampicillin sodium is also a factor to be considered, although
this patient’s vision already showed no light perception
prior to administration of the intravitreal ampicillin. In this
case, the eye was anatomically salvaged with this treatment
regimen, although without visual recovery.
Summary Statement
A paper about postoperative endophthalmitis due to atypical
bacteria: Streptococcus uberis,w h i c hw a sn o tp r e v i o u s l y
described as pathogenic to human eye. This paper describes
how the diagnosis was made, the treatment, the poor
outcome, and a brief discussion about the treatment with
intravitreal ampicillin sodium used in this case.
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